Fireside Chat: The Future of Clinical Trials and Site Engagement

The COVID-19 pandemic has proven that research can be done more efficiently. To make these efficiencies sustainable, the sites’ perspective must be considered. Sponsors, CROs, and sites should engage early in the process to understand what is feasible--what works well and what must be fixed--to improve the way we develop new therapies and interventions that advance human health.

To discuss burning topics like these, Advarra presents Fireside Chats—a series of video conversations between research community leaders.

In this conversation, Gadi Saarony, CEO of Advarra, speaks with Deb Tatton, Senior Vice President, Global Clinical Operations at Parexel. Gadi and Deb talk about the challenges sites face, bring awareness to these issues, and propose possible ways sponsors and CROs can work more collaboratively with sites to improve study startup and address the changing clinical trial landscape.

Discussion Topics:

• Define the research challenges sites face, including pressure to quickly adapt site practices and meet expectations of the “new normal”
• Describe the enhanced role of technology (site and sponsor/CRO) in the future of clinical trials
• Outline questions sponsors and CROs can ask sites—and sites can ask sponsors and CROs—to help ensure clinical development plans are feasible and appropriate

Who should watch?

Clinical research professionals involved in study startup and study conduct from sponsor, CRO, institutional and site organizations.

Presented By